| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3007173 |
| Synonym(s) | alpha-lipoic acid |
| Definition | Lipoic acid is a compound used for diabetic neuropathy and as a nutritional supplement. It has also demonstrated potent inhibition of NDM-1 and synergistic effects against other metallo-beta-lactamases when paired with meropenem. |
| SMILES | O=C(O)CCCCC1CCSS1 |
| PubChem | 864 |
| ChEBI | 16494 |
| ChEMBL | CHEMBL33864 |
| AMR Gene Family | NDM beta-lactamase |
| Drug Class | penicillin beta-lactam, cephalosporin, carbapenem |
| Resistance Mechanism | antibiotic inactivation |
| Classification | 23 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + determinant of antibiotic resistance + antibiotic inactivation [Resistance Mechanism] + antibiotic inactivation enzyme + hydrolysis of antibiotic conferring resistance + hydrolysis of beta-lactam antibiotic by metallo-beta-lactamase + beta-lactamase + antibiotic molecule + resistance-modifying agents + inhibitor of antibiotic resistance mechanism + beta-lactam antibiotic + class B (metallo-) beta-lactamase + subclass B1 (metallo-) beta-lactamase + beta-lactamase inhibitor + penicillin beta-lactam [Drug Class] + cephalosporin [Drug Class] + carbapenem [Drug Class] + metallo-beta-lactamase inhibitor + imipenem [Antibiotic] + NDM beta-lactamase [AMR Gene Family] + meropenem [Antibiotic] + ertapenem [Antibiotic] |
| Parent Term(s) | 2 ontology terms | Show |
| Publications | Zhang B, et al. 2022. J Antibiot (Tokyo) 75(5):282-286 Methimazole and α-lipoic acid as metallo-β-lactamases inhibitors. (PMID 35197545) |
| Curator | Description | Most Recent Edit |
|---|